158 related articles for article (PubMed ID: 36474192)
1. MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.
Zhang X; Han Y; Liu S; Guo B; Xu S; He Y; Liu L
Cell Mol Biol Lett; 2022 Dec; 27(1):107. PubMed ID: 36474192
[TBL] [Abstract][Full Text] [Related]
2. Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma.
Yang L; Li H; Luo A; Zhang Y; Chen H; Zhu L; Yang D
J Nanobiotechnology; 2024 Apr; 22(1):168. PubMed ID: 38610015
[TBL] [Abstract][Full Text] [Related]
3. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
4. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
5. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
6. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic, anti-proliferative, and apoptotic evaluation of Ramalina sinensis (Ascomycota, Lecanoromycetes), lichenized fungus on oral squamous cell carcinoma cell line; in-vitro study.
Koopaie M; Karimi H; Sohrabi M; Norouzi H
BMC Complement Med Ther; 2023 Aug; 23(1):296. PubMed ID: 37608377
[TBL] [Abstract][Full Text] [Related]
8. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
Zhao Q; Cheng X; Yu W; Bi Y; Guo J; Ma Q; Gong Y; He L; Yu X
Phytomedicine; 2021 Nov; 92():153723. PubMed ID: 34482221
[TBL] [Abstract][Full Text] [Related]
9. Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.
Cao M; Shi E; Wang H; Mao L; Wu Q; Li X; Liang Y; Yang X; Wang Y; Li C
Int J Nanomedicine; 2022; 17():4293-4306. PubMed ID: 36134201
[TBL] [Abstract][Full Text] [Related]
10. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
11. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
12. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
[TBL] [Abstract][Full Text] [Related]
13. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
[TBL] [Abstract][Full Text] [Related]
14. A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma.
Khammanivong A; Saha J; Spartz AK; Sorenson BS; Bush AG; Korpela DM; Gopalakrishnan R; Jonnalagadda S; Mereddy VR; O'Brien TD; Drewes LR; Dickerson EB
Vet Comp Oncol; 2020 Sep; 18(3):324-341. PubMed ID: 31661586
[TBL] [Abstract][Full Text] [Related]
15. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
16. Stable Loading and Delivery of Icaritin Using PEG-PCL Micelles for Effective Treatment of Oral Squamous Cell Carcinoma.
Yang JG; Zhang J; Chen XJ; Zhou G
Curr Drug Deliv; 2021; 18(7):975-983. PubMed ID: 33305705
[TBL] [Abstract][Full Text] [Related]
17. Hematoporphyrin monomethyl ether mediated photodynamic therapy inhibits oral squamous cell carcinoma by regulating the P53-miR-21-PDCD4 axis via singlet oxygen.
Meng P; Sun Y; Li E; Liu Y; Wang C; Song L
Lasers Med Sci; 2022 Aug; 37(6):1-9. PubMed ID: 35260928
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma.
Lan Q; Wang S; Chen Z; Hua J; Hu J; Luo S; Xu Y
Int J Pharm; 2024 Jan; 649():123667. PubMed ID: 38048890
[TBL] [Abstract][Full Text] [Related]
19. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]